Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor

OBJECTIVES: Traditional cancer therapy and regular immunotherapy are ineffective for treating triple‐negative breast cancer (TNBC) patients. Recently, chimeric antigen receptor‐engineered natural killer cells (CAR NK) have been applied to target several hormone receptors on different cancer cells to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Zhou, Yehui, Huang, Kuo‐Hsiang, Fang, Xujie, Li, Ying, Wang, Feifei, An, Li, Chen, Qingfei, Zhang, Yunchao, Shi, Aihua, Yu, Shuang, Zhang, Jingzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445407/
https://www.ncbi.nlm.nih.gov/pubmed/32592435
http://dx.doi.org/10.1111/cpr.12858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445407/
https://www.ncbi.nlm.nih.gov/pubmed/32592435
http://dx.doi.org/10.1111/cpr.12858

Ejemplares similares